Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.

Author
:
CC Thompson
BK Dayyeh
Kushnir V
RF Kushner
P Jirapinyo
AB Schorr
LJ Aronne
A Amaro
DL Jaffe
AR Schulman
D Early
AC Stein
R Sharaiha
SA Edmundowicz
JM Bohning
MD Jensen
AP Shukla
C Apovian
DW Kim
D Tran
A Zarrinpar
MB Ryan
M Young
A Lowe
M Haas
H Goldsmith
J McCrea
S Sullivan
Abstract
:

The AspireAssist is the first Food and Drug Administration-approved endoluminal device indicated for treatment of class II and III obesity.
Year of Publication
:
2019
Journal
:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Volume
:
15
Issue
:
8
Number of Pages
:
1348-1354
ISSN Number
:
1550-7289
URL
:
https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(18)31266-8
DOI
:
10.1016/j.soard.2019.04.026
Short Title
:
Surg Obes Relat Dis
Download citation